日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

预测前列腺癌放射治疗的剂量反应:在随机 III 期 NRG/RTOG 0126 和 SAKK 09/10 试验中验证放射特征

Dal Pra, A; Ghadjar, P; Ryu, H M; Proudfoot, J A; Hayoz, S; Michalski, J M; Spratt, D E; Liu, Y; Schär, C; Berlin, A M; Zwahlen, D R; Simko, J P; Hölscher, T; Efstathiou, J A; Polat, B; Sandler, H M; Hildebrandt, G; Parliament, M B; Mueller, A-C; Dayes, I S; Plasswilm, L; Correa, R J M; Robertson, J M; Karrison, T G; Davicioni, E; Hall, W A; Feng, F Y; Pollack, A; Thalmann, G N; Nguyen, P L; Aebersold, D M; Tran, P T; Zhao, S G

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy

新辅助化疗免疫疗法治疗IIIA期非小细胞肺癌患者的肿瘤免疫动力学和长期临床结果

Schmid, Dominic; Sobottka, Bettina; Manzo, Massimiliano; Trüb, Marta; Leonards, Katharina; Herzig, Petra; Oyewole, Oluwaseun Rume-Abiola; Jermann, Philip; Hayoz, Stefanie; Savic Prince, Spasenija; Tochtermann, Giulia; Natoli, Marina; Pless, Miklos; Bettini, Adrienne; Früh, Martin; Mauti, Laetitia A; Britschgi, Christian; Peters, Solange; Mark, Michael; Ochsenbein, Adrian F; Janthur, Wolf-Dieter; Waibel, Christine; Mach, Nicolas; Froesch, Patrizia; Buess, Martin; Bohanes, Pierre; Gonzalez, Michel; Alborelli, Ilaria; Rothschild, Sacha I; Koelzer, Viktor Hendrik; Zippelius, Alfred

Chrono-immunotherapy as a low-hanging fruit for cancer treatment? A call for pragmatic randomized clinical trials

时间免疫疗法是癌症治疗的捷径吗?呼吁开展务实的随机临床试验

Özdemir, Berna C; Bill, Ruben; Okyar, Alper; Scheiermann, Christoph; Hayoz, Stefanie; Olivier, Timothée

Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial

PIK3CA突变结肠癌患者的阿司匹林辅助治疗:SAKK 41/13前瞻性随机安慰剂对照双盲试验

Güller, Ulrich; Hayoz, Stefanie; Horber, Daniel; Jochum, Wolfram; De Dosso, Sara; Koeberle, Dieter; Schacher, Sabina; Inauen, Roman; Stahl, Michael; Delaunoit, Thierry; Ettrich, Thomas; Bodoky, György; Michel, Pierre; Koessler, Thibaud; Rothgiesser, Karin; Calmonte, Sandra; Joerger, Markus

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)

瑞士临床癌症研究组 (SAKK) 开展的 I 期和 I/II 期研究者发起的临床试验的回顾性分析

Koster, K-L; Colombo, I; Hayoz, S; Eckhardt, K; Rojas Mora, A; Hess, D; Britschgi, C; Haefliger, S; Imbimbo, M; Bertoni, F; Homicsko, K; von Moos, R; Sessa, C; Joerger, M; Stathis, A

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14

针对接受新辅助治疗的可切除 III 期非小细胞肺癌 (NSCLC) 患者的性别特异性疗效和安全性结果:SAKK 试验 16/96、16/00、16/01、16/08 和 16/14 的汇总分析

Frehner, L; Schär, S; Hayoz, S; Guckenberger, M; Finazzi, T; Mark, M; Addeo, A; Mauti, L A; Betticher, D; Stupp, R; Curioni-Fontecedro, A; Peters, S; Früh, M; Rothschild, S I; Pless, M; König, D; Opitz, I; Ris, H B; Özdemir, B C; Schmid, S

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update

晚期未经治疗的滤泡性淋巴瘤患者接受为期六个月的利妥昔单抗-来那度胺方案治疗:SAKK 35/10 试验 10 年随访更新

Kimby, Eva; Schär, Sämi; Pirosa, Maria Cristina; Vanazzi, Anna; Mey, Ulrich M; Rauch, Daniel; Wahlin, Björn E; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés José María; Krasniqi, Fatime; Voegeli, Michèle; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Mamot, Christoph; Mingrone, Walter; Stathis, Anastasios; Dirnhofer, Stefan; Hayoz, Stefanie; Østenstad, Bjørn; Zucca, Emanuele

First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study

小细胞肺癌一线化疗联合免疫疗法:一项双边真实世界研究的结果

Moliner, Laura; Zellweger, Núria; Schmid, Sabine; Bertschinger, Martina; Waibel, Christine; Cerciello, Ferdinando; Froesch, Patrizia; Mark, Michael; Bettini, Adrienne; Häuptle, Pirmin; Blum, Veronika; Holer, Lisa; Hayoz, Stefanie; Früh, Martin; Ahmed, Samreen; Bhagani, Shradha; Steele, Nicola; Gray, Hannah-Leigh; Robinson, Stephen D; Davidson, Michael; Cox, Samantha; Khalid, Taha; Geldart, Tom R; Nolan, Luke; Scott, Deborah C; Hennah, Lindsay; Newsom-Davis, Tom; Rathbone, Emma; Handforth, Catherine; Denton, Arshi; Merchant, Shairoz; Blackhall, Fiona; Mauti, Laetitia A; Califano, Raffaele; Rothschild, Sacha I

Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment-A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01, 16/08, and 16/14: A Brief Report

新辅助治疗后未行根治性手术的可切除III期非小细胞肺癌患者的预后——SAKK 16/96、16/00、16/01、16/08和16/14试验的回顾性分析:简要报告

Raimann, Sabine; Schär, Sämi; Hayoz, Stefanie; Guckenberger, Matthias; Finazzi, Tobias; Opitz, Isabelle; Schmid, Sabine; Mark, Michael; Addeo, Alfredo; Mauti, Laetitia A; Betticher, Daniel C; Ris, Hans-Beat; Stupp, Roger; Curioni-Fontecedro, Alessandra; Peters, Solange; Früh, Martin; Rothschild, Sacha I; Pless, Miklos; König, David

AI-Assisted Optical Coherence Tomography Segmentation for Enhanced Diagnosis of Inherited Retinal Diseases

人工智能辅助光学相干断层扫描分割技术在遗传性视网膜疾病诊断中的应用

Peter, Virginie G; Hayoz, Michel; Scandella, Davide; Sznitman, Raphael; Escher, Pascal; Zinkernagel, Martin S